Northern Peptide Collective Research Library
LL-37 Research
LL-37 is the active antimicrobial peptide cleaved from the human cathelicidin precursor hCAP18. It is a major research target in innate immunity and host-defense biology.
Compound overview
What is LL-37?
LL-37 is the active antimicrobial peptide cleaved from the human cathelicidin precursor hCAP18. It is a major research target in innate immunity and host-defense biology.
Research includes antimicrobial activity, membrane interactions, immune signaling, epithelial biology and wound models. Biological effects are concentration- and context-dependent.
Research themes
LL-37 research focus
These are literature-navigation themes, not therapeutic claims. Review primary sources for model, methods, formulation, route, endpoints, sample size and limitations.
Independent literature
Researching LL-37
Use primary scientific databases as the starting point. Search results can contain studies using different analogs, salts, formulations or experimental models, so confirm molecular identity before comparing outcomes.
Separate cell and animal models from human trials. Note whether a study is exploratory, randomized, controlled, blinded, replicated or peer reviewed. For investigational compounds, regulatory status should remain explicit.
NPC catalogue
LL-37 research material
No direct NPC catalogue product is mapped to this research hub right now. Use catalogue search to check current availability and product naming.
Search LL-37 in catalogueAnalytical documentation
LL-37 quality, testing & COAs
For research materials, batch-specific documentation is more useful than a generic purity statement. Confirm that analytical documentation identifies the material, lot or batch and test methods used.
Frequently asked questions
LL-37 FAQ
What is LL-37?
LL-37 is the active antimicrobial peptide cleaved from the human cathelicidin precursor hCAP18. It is a major research target in innate immunity and host-defense biology.
What research areas are associated with LL-37?
Research includes antimicrobial activity, membrane interactions, immune signaling, epithelial biology and wound models. Biological effects are concentration- and context-dependent.
How strong is the evidence for LL-37?
The evidence context for this hub is: Extensive innate-immunity and preclinical literature. Review primary sources and distinguish preclinical models from human clinical research.
Where can I find independent LL-37 research?
Use PubMed, ClinicalTrials.gov where relevant, journal databases and the references within peer-reviewed review articles. Search by both the compound name and known aliases.
How do I verify an NPC LL-37 batch?
Use NPC's COA Verification resources and match documentation to the exact product lot where batch-specific records are available.
Does this page provide dosing or medical guidance?
No. Northern Peptide Collective products and this research library are for research purposes only and are not intended for human consumption or medical use.